• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典反流试验:对伴有扩张性膀胱输尿管反流的儿童进行的一项随机对照试验的回顾。

The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux.

机构信息

Pediatric Uro-Nephrologic Center, The Queen Silvia Children's Hospital, University of Gothenburg, SE-416 85 Göteborg, Sweden.

出版信息

J Pediatr Urol. 2011 Dec;7(6):594-600. doi: 10.1016/j.jpurol.2011.05.006. Epub 2011 Jul 31.

DOI:10.1016/j.jpurol.2011.05.006
PMID:21807562
Abstract

OBJECTIVES

To evaluate prophylaxis and endoscopic injection for children with dilating vesicoureteral reflux (VUR) compared to surveillance, regarding urinary tract infection (UTI) recurrence, new renal damage, VUR outcome, and impact of lower urinary tract (LUT) dysfunction on these outcomes.

PATIENTS AND METHODS

203 children (128 girls and 75 boys), aged 1 to <2 years, with VUR grade III or IV were randomized to antibiotic prophylaxis (n = 69), endoscopic injection (n = 66) or surveillance (n = 68). Voiding cystourethrography, dimercaptosuccinic acid scintigraphy and optional LUT function assessment were performed before randomization and after 2 years.

RESULTS

There were 67 febrile UTIs in 42 girls and 8 in 7 boys (p = 0.0001). In girls, recurrence rate was 19% on prophylaxis, 23% with endoscopic treatment and 57% on surveillance (p = 0.0002). In boys, there was no difference between treatment groups. New damage was seen in 13 girls: 8 on surveillance, 5 in the endoscopic group and none on prophylaxis (p = 0.0155), and in 2 boys. In 13 children with no or non-dilating VUR after 1 injection, dilating VUR reappeared at the 2-year follow up. LUT dysfunction at follow up was associated with persistence of VUR.

CONCLUSION

In girls, prophylaxis reduced the rate of UTI recurrence and new renal damage, and endoscopic injection the rate of UTI recurrence. Boys did not benefit from active treatment.

摘要

目的

评估与观察相比,预防性抗生素治疗和内镜下注射治疗对伴有扩张型膀胱输尿管反流(VUR)的儿童在尿路感染(UTI)复发、新的肾损伤、VUR 结局以及下尿路(LUT)功能障碍对这些结局的影响。

患者和方法

203 名年龄在 1 至<2 岁之间、具有 III 或 IV 级 VUR 的儿童(128 名女孩和 75 名男孩)被随机分为抗生素预防组(n=69)、内镜注射组(n=66)或观察组(n=68)。在随机分组前和 2 年后进行排尿性膀胱尿道造影、二巯丁二酸闪烁扫描和可选的 LUT 功能评估。

结果

42 名女孩中有 67 例出现发热性 UTI,7 名男孩中有 8 例(p=0.0001)。在女孩中,预防组的复发率为 19%,内镜治疗组为 23%,观察组为 57%(p=0.0002)。在男孩中,各组之间无差异。13 名女孩出现新的损伤:观察组 8 例,内镜组 5 例,预防组无 1 例(p=0.0155),2 名男孩也出现新的损伤。在 13 名接受 1 次注射后无或非扩张性 VUR 的儿童中,扩张性 VUR 在 2 年随访时再次出现。随访时 LUT 功能障碍与 VUR 的持续存在相关。

结论

在女孩中,预防性抗生素治疗降低了 UTI 复发和新的肾损伤的发生率,而内镜下注射治疗降低了 UTI 复发的发生率。男孩则未从积极治疗中获益。

相似文献

1
The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux.瑞典反流试验:对伴有扩张性膀胱输尿管反流的儿童进行的一项随机对照试验的回顾。
J Pediatr Urol. 2011 Dec;7(6):594-600. doi: 10.1016/j.jpurol.2011.05.006. Epub 2011 Jul 31.
2
The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome.瑞典婴幼儿重度反流试验:研究报告及膀胱输尿管反流结果
J Pediatr Urol. 2017 Apr;13(2):130-138. doi: 10.1016/j.jpurol.2016.08.026. Epub 2016 Oct 24.
3
The Swedish infant high-grade reflux trial: UTI and renal damage.瑞典婴幼儿重度反流试验:尿路感染与肾损伤
J Pediatr Urol. 2017 Apr;13(2):146-154. doi: 10.1016/j.jpurol.2016.12.023. Epub 2017 Feb 2.
4
The Swedish reflux trial in children: III. Urinary tract infection pattern.瑞典儿童反流研究 III:尿路感染模式。
J Urol. 2010 Jul;184(1):286-91. doi: 10.1016/j.juro.2010.01.061. Epub 2010 May 20.
5
Parental experiences and preferences regarding the treatment of vesicoureteral reflux.父母对于膀胱输尿管反流治疗的经历和偏好。
Scand J Urol Nephrol. 2012 Feb;46(1):26-30. doi: 10.3109/00365599.2011.621144. Epub 2011 Oct 19.
6
Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.原发性膀胱输尿管反流患儿内镜治疗的回顾性研究及失败因素的多因素分析
Scand J Urol. 2014 Dec;48(6):565-70. doi: 10.3109/21681805.2014.938695. Epub 2014 Jul 16.
7
The Swedish reflux trial in children: II. Vesicoureteral reflux outcome.瑞典儿童反流研究 II:膀胱输尿管反流结果。
J Urol. 2010 Jul;184(1):280-5. doi: 10.1016/j.juro.2010.01.059. Epub 2010 May 20.
8
The Swedish reflux trial in children: IV. Renal damage.瑞典儿童反流研究 IV:肾损伤。
J Urol. 2010 Jul;184(1):292-7. doi: 10.1016/j.juro.2010.01.060. Epub 2010 May 23.
9
Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents.儿童膀胱输尿管反流内镜治疗的长期疗效:不同填充剂的比较。
J Pediatr Urol. 2013 Feb;9(1):71-6. doi: 10.1016/j.jpurol.2011.12.004. Epub 2011 Dec 31.
10
Endoscopic treatment of vesicoureteral reflux in an adult population: Can we teach our adult urology colleagues?成人人群中膀胱输尿管反流的内镜治疗:我们能否教我们的成人泌尿科同事?
J Pediatr Urol. 2010 Dec;6(6):600-4. doi: 10.1016/j.jpurol.2010.01.012. Epub 2010 Mar 2.

引用本文的文献

1
Impact of antibiotic prophylaxis on urinary tract infection recurrence in children Rapid review.抗生素预防对儿童尿路感染复发的影响 快速综述
Can Urol Assoc J. 2024 Dec;18(12):E387-E396. doi: 10.5489/cuaj.8678.
2
Effectiveness of various treatment modalities in children with vesicoureteral reflux grades II-IV: a systematic review and network meta-analysis.各种治疗方式在 II-IV 级膀胱输尿管反流患儿中的疗效:系统评价和网络荟萃分析。
BMJ Paediatr Open. 2023 Nov;7(1). doi: 10.1136/bmjpo-2023-002096.
3
Conflicting views of physicians and surgeons concerning pediatric urinary tract infection: a comparative review.
医师和外科医生对小儿尿路感染的观点相悖:一项比较性综述。
Pediatr Radiol. 2023 Dec;53(13):2651-2661. doi: 10.1007/s00247-023-05771-x. Epub 2023 Sep 30.
4
Frequency of Urinary Tract Infection When Diagnosing Vesico Uretheral Reflux in Children in Tuzla Canton.图兹拉州儿童诊断膀胱输尿管反流时尿路感染的发生率
Mater Sociomed. 2023 Mar;35(1):4-7. doi: 10.5455/msm.2023.35.4-7.
5
Antimicrobial Pharmacotherapy Management of Urinary Tract Infections in Pediatric Patients.小儿患者尿路感染的抗菌药物治疗管理
J Pharm Technol. 2018 Apr;34(2):62-81. doi: 10.1177/8755122518755402. Epub 2018 Jan 31.
6
Diagnosis and management of community-acquired urinary tract infection in infants and children: Clinical guidelines endorsed by the Saudi Pediatric Infectious Diseases Society (SPIDS).婴幼儿社区获得性尿路感染的诊断与管理:沙特儿科传染病学会(SPIDS)认可的临床指南
Int J Pediatr Adolesc Med. 2021 Jun;8(2):57-67. doi: 10.1016/j.ijpam.2021.03.001. Epub 2021 Mar 11.
7
Management of Vesicoureteral Reflux: What Have We Learned Over the Last 20 Years?膀胱输尿管反流的管理:过去20年我们学到了什么?
Front Pediatr. 2021 Mar 31;9:650326. doi: 10.3389/fped.2021.650326. eCollection 2021.
8
Girls and renal scarring as risk factors for febrile urinary tract infection after stopping antibiotic prophylaxis in children with vesicoureteral reflux.女孩和肾脏瘢痕是抗反流手术后停止预防性使用抗生素后儿童发热性尿路感染的危险因素。
World J Urol. 2021 Jul;39(7):2587-2595. doi: 10.1007/s00345-020-03524-1. Epub 2021 Jan 3.
9
Role of Antibiotic Prophylaxis in the Management of Antenatal Hydronephrosis, Vesicoureteral Reflux, and Ureterocele in Infants.抗生素预防在婴儿产前肾积水、膀胱输尿管反流和输尿管囊肿管理中的作用
Cureus. 2020 Jul 8;12(7):e9064. doi: 10.7759/cureus.9064.
10
Brazilian consensus on vesicoureteral reflux-recommendations for clinical practice.巴西尿路上皮反流共识——临床实践建议。
Int Braz J Urol. 2020 Jul-Aug;46(4):523-537. doi: 10.1590/S1677-5538.IBJU.2019.0401.